In early studies, a new drug under investigation called eloralintide helped some adults lose nearly 50 pounds in under a year and it's not a GLP 1: https: bit.ly 43nPJnS Eloralintide Phase 2 Paper Out: 20% weight loss after 48 weeks : r Zepbound Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48 week phase 2, multicentre, double blind, randomised, placebo controlled trial The Lancet Weight loss with retatrutide as compared to licenced obesity Download Scientific Diagram Eloralintide (LY 3841136) Amylin Receptor Activator MedChemExpress